Burke Bioventures provides strategic advice and scientific direction for life science companies, entrepreneurs, investors, and foundations interested in translating research-stage technology breakthroughs into therapeutic products. Focus areas include nanotechnology, targeting,
and RNA.

Applying new science and technology
for better medicines
Our offerings, tailored according to the needs of each client, include:
Advisory services in matters pertaining to biopharma- ceutical R&D at program stages ranging from discovery to early clinical development.
Interim Management, to supplement your existing executive team or serve in an interim operational capacity.
Technology diligence in support of venture investment, licensing, and M&A.
News & Events

Nature Reviews Drug Discovery cover features article...

The September issue of Nature Reviews Drug Delivery features...